Deerfield Management Company, L.P. (Series C) Galapagos Nv Call Options Transaction History
Deerfield Management Company, L.P. (Series C)
- $4.04 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding GLPG
# of Institutions
87Shares Held
12.2MCall Options Held
224KPut Options Held
106K-
Tang Capital Management LLC San Diego, CA2.16MShares$55 Million4.46% of portfolio
-
Bvf Inc San Francisco, CA1.57MShares$39.9 Million1.62% of portfolio
-
Prosight Management, LP Dallas, TX1.03MShares$26.1 Million8.37% of portfolio
-
Deep Track Capital, LP Greenwich, CT781KShares$19.9 Million0.95% of portfolio
-
Segall Bryant & Hamill, LLC Chicago, IL686KShares$17.4 Million0.27% of portfolio
About GALAPAGOS NV
- Ticker GLPG
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,835,500
- Market Cap $1.67B
- Description
- Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...